Whilst clinical trials have shown modest improvements in cholesterol levels amongst patients using Ozempic, these changes appear largely secondary to weight loss rather than direct lipid-lowering effects
Tirzepatide targets two receptors (GLP-1, GIP) and produced 22.5% weight loss
Tirzepatide targets two, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Improved Satiety : Enhances feelings of fullness after meals, which can help prevent overeating
We believe that weight-loss medication, while potentially helpful, is most effective when used responsibly and in conjunction with other health strategies such as balanced eating, regular exercise, and sufficient sleep
For patients who already have an existing GLP-1 prescription and are not changing their dose, Amazon offers a separate on-demand telehealth renewal pathway that operates independently of the full GLP-1 Management Program